September 2019 FDA Recall Vivitrol by Alkermes, Inc.
D-0119-2020 - Labeling

This Class II drug recall was voluntarily initiated by Alkermes, Inc. on September 26, 2019 for the product Vivitrol. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0119-2020

Reason for Recall
Labeling: Not Elsewhere Classified. Drug product kit recalled due to 1 inch needles being placed in the 1 1/2 inch needle cardboard sleeve labelled as administration needles. The product vial is not impacted.
Initiated
09-26-2019
Reported
10-09-2019
Quantity
16,231 kits

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide USA and Canada
Vivitrol (naltrexone for extended-release injectable suspension) 380 mg/vial. Each Carton Contains: 1) One vial of 380 mg of Vivitrol, 2) One vial containing 4 mL of diluent, 3) One 5-mL prepackaged syringe, 4) One 20-gauge 1-inch needle, 5) Two 20-gauge 1.5-inch safety needles, 6) Two 20-gauge 2-inch safety needles. Rx Only. Manufactured and marketed by: Alkermes, Inc. Kit NDC: 65757-300-01

Batch or Lot Expiration Information

Lot# Lot 2019-1002T, 2019-1003T, Exp 05/2021

Affected Packages Involved in this Recall